-+ 0.00%
-+ 0.00%
-+ 0.00%

PUMA BIOTECHNOLOGY INITIATES ALISCA®-LUNG2, A PHASE II TRIAL OF ALISERTIB IN COMBINATION WITH PACLITAXEL FOR THE TREATMENT OF PATIENTS WITH ADVANCED SMALL CELL LUNG CANCER

Reuters·09/17/2026 20:07:00

Please log in to view news